Relief Therapeutics Holding SA
OTC:RLFTF
Relief Therapeutics Holding SA
OTC:RLFTF
Price:
0.73
USD
-9.85%
Market Cap:
$9.2m
Relative Value
The Relative Value of one
RLFTF
stock under the Base Case scenario is
0.15
USD.
Compared to the current market price of 0.73 USD,
Relief Therapeutics Holding SA
is
Overvalued by 80%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RLFTF
Relative Value
Base Case
0.15
USD
Overvaluation 80%
Multiples Across Competitors
RLFTF Competitors Multiples
Relief Therapeutics Holding SA Competitors
Relief Therapeutics Holding SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
Relief Therapeutics Holding SA
OTC:RLFTF
|
437m USD | 107.8 | -25.6 | -24 | -21.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
396.4B USD | 6.5 | 95.6 | 15.7 | 21.8 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD | 5.5 | 26.1 | 15 | 15 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.6B USD | 6.1 | 21.2 | 13.2 | 16.3 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.8B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.3B USD | 5.7 | 18.1 | 13.6 | 15.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3.2 | 34.8 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
38B EUR | 10.9 | 35.1 | 38.1 | 38.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
